Taiwan foam dressing market set to grow at 5% CAGR through 2033, forecasts GlobalData

The increasing prevalence of chronic conditions, such as diabetes and pressure ulcers, is fueling the need for advanced wound care solutions in Taiwan. Against this backdrop, the Taiwan foam dressing market is projected to grow at a compound annual growth rate (CAGR) of 5 per cent through 2033, forecasts GlobalData.

GlobalData’s latest report, “Taiwan Wound Dressings Market Size (Value, Volume, ASP) by Segments, and Forecast, 2015-2033,” reveals that Taiwan foam dressing market accounted for approximately 5 per cent of the Asia-Pacific market in 2023, as the country continues to advance in the wound care sector.

Kanchan Chauhan, Medical Devices Analyst at GlobalData, states, “With chronic wounds such as diabetic foot ulcers, leg ulcers, and bedsores becoming more common among the elderly and diabetic patients, the demand for wound care products with superior moisture management, anti-adhesive properties, and enhanced tissue regeneration is increasing”.

AMS BioteQ’s “SIPSIP Foam” has recently become the first Taiwanese “cotton-based wound dressing” to secure Japan’s first-class medical device permit from the Pharmaceuticals and Medical Devices Agency. This approval underscores the product’s notable features, including absorbency, tissue support, non-allergenic properties, and a structure suited for ageing and diabetic populations. Following this approval, AMS BioteQ plans to extend its reach in Japan and explore opportunities in Southeast Asia and other ASEAN markets.

“In conclusion, Taiwan’s strengths in information and communication technology, a comprehensive manufacturing supply chain, and excellent clinical medical capabilities position the country as a key partner in developing biomedical products. As Taiwan addresses healthcare needs and accelerates industry development, its role in global collaborations will only grow,” adds Chauhan.